ENVISION INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Envision Healthcare Corp To Contact The Firm
NEW YORK, July 25, 2017 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Envision Healthcare Corp ("Envision" or the "Company") (NYSE:EVHC).
The investigation focuses on whether the Company and its executives violated federal securities laws. Specifically, on July 24, 2017, The New York Times reported on a study of Envision's billing practices conducted by researchers at Yale University. The study asserted that emergency rooms associated with the Company were substantially likely to engage in so-called "surprise billing," by assigning out-of-network doctors to treat patients and then charging higher rates than were expected.
Following this news, Envision's share price declined during intraday trading on July 24, 2017, causing harm to investors.
If you invested in Envision stock or options and would like to discuss your legal rights, click here: www.faruqilaw.com/EVHC. There is no cost or obligation to you.
You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to [email protected].
CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
[email protected]
Telephone: (877) 247-4292 or (212) 983-9330
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
SOURCE Faruqi & Faruqi, LLP
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article